GL1X · GenesisL1 explorer

MolNFT v1 · #149987 · protein

P53 cancer mutant Y220C in complex with small-molecule stabilizer PK9318

6GGB · Cellular tumor antigen P53: “P53 cancer mutant Y220C in complex with small-molecule stabilizer PK9318”. X-ray diffraction, 2 ligands (EXQ, ZN), 5 pockets (best druggability 0.69). MolNFT v1 #149987 on GenesisL1: 3D structure…

PDB
6GGB
Type
protein
Length
396 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Cellular tumor antigen P53
UniProt
P04637
Ligands
EXQ, ZN
Pockets
5 · best druggability 0.69

Structure

x-ray diffraction · 2 distinct chains · 8% helix, 33% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ACellular tumor antigen P53protein1989% helix, 33% strandP04637
BCellular tumor antigen P53protein1988% helix, 33% strandP04637

Ligands and binding sites

  • EXQ · [9-ethyl-7-(4-methylthiophen-2-yl)carbazol-3-yl]methyl-methyl-azanium · ligand · 2 copies · chains A, B
  • ZN · Zinc ion · metal · 2 copies · chains A, B
  • EDO · 1,2-ethanediol · additive · chains A
  • GOL · Glycerol · additive · chains B
  • EPE · 4-(2-hydroxyethyl)-1-piperazine ethanesulfonic acid · additive · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15880.690.7868EDO, EPE
2660.400.8018EXQ
3660.400.8017EXQ
4880.350.7518empty
5500.350.7919empty

Interfaces

1 interface between chains.

  • A–B · 341 Ų buried · 3 hydrogen bonds · protein-protein

Compared structures

  • 6GGB · p53 cancer mutant Y220C in complex with small-molecule stabilizer PK9318 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.